Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

Genetically transmitted predisposition to develop colorectal cancers.

Cancer Family Syndrome; Familial Cancer Syndrome; Hereditary Nonpolyposis Colorectal Cancer (HNPCC); Hereditary Nonpolyposis Colorectal Carcinoma.

First described by Alder Scott Warthin, an American pathologist, in 1913.

Five percent of the colorectal cancer population.

Both clinical forms of HNPCC are autosomal dominant with a penetrance of 85 to 90%. Two DNA mismatch repair genes are closely linked to the disease: hMSH2 gene in chromosome 2p and hMLS1 gene in chromosome 3p. Mutations in these genes account for 90% of all known HNPCC families.

Defective DNA mismatch repair leads to accumulation of mutations. The mutation load can be identified as errors in long tandem repeat sequences, which produce microsatellite instability.

Familial history, colonic screening examinations, DNA genetic testing.

Two clinical forms described:

  • Lynch Syndrome I: Familial predisposition to early-onset colorectal cancer (mainly right colon).
  • Lynch Syndrome II: Same features and familial predisposition with an associated predisposition for other primary cancers (often female reproductive organs, particularly endometrial carcinoma). This variant is not easily recognized because of the lack of phenotypical expression as familiar adenomatous polyposis.

All precautions before anesthesia will be dictated by those associated with the patient's underlying medical condition.

Anesthetic considerations are those associated with the surgical procedure only or any associated medical conditions.

No specific pharmacological implications except for patients receiving chemotherapy.

de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, et al: Surveillance for hereditary nonpolyposis colorectal cancer: A long-term study on 114 families. Dis Colon Rectum 45:1588, 2002.
Mitchell RJ, Farrington SM, Dunlop MG, et al: Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: A HuGE review. Am J Epidemiol 156:885, 2002.  [PubMed: 12419761]
Wagner A, Tops C, Wijnen JT, et al: Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J Med Genet 39:833, 2002.  [PubMed: 12414824]

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.